This company has a phase 3 clinical trial update due in Q1 2021. Hold until the release or hold long term. Now appears to be a decent entry point. Make sure you sell after the 31st if it doesn't explode. Good Luck!
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
